Orbitech오르비텍

Orbitech's trailing results are loss-making at the operating line, though net income is positive after non-operating items.

Orbitech, a Seoul-based KOSDAQ company serving nuclear power inspection and aerospace parts, reported trailing twelve-month revenue of ₩68.3B to H1 2026 with an operating loss of ₩12.7B and net income of ₩8.1B. Its share price is ₩4,335, down 21.3% over one month but up 22.5% over one year, well below its 52-week high of ₩16,410.

What stands out

• Trailing operating income is negative at about -₩12.7B (-18.5% margin), while net income is positive at ₩8.1B, so the profit appears to rely on non-operating items; the data does not break this down.
• 2025 was weaker than 2024: revenue fell 12.9% to ₩57.9B and the operating loss widened to ₩14.0B, compared with a small operating profit of ₩0.7B in 2024.
• Free cash flow is negative at about -₩20.0B on a trailing basis, and borrowings of ₩13.9B exceed cash of ₩7.1B.
• Recent filings include a convertible bond issue decision (August 2026), amendments to share sale disclosures, and a conversion price adjustment (July 2026).
• Valuation shows P/E of 18.1 and P/B of 1.4 with no dividend; the data includes no analyst ratings or price targets, and no recent news headlines were provided.

What to watch

• Next results and whether the operating loss narrows from the trailing -₩12.7B level.
• Terms and effects of the convertible bond issue and conversion price adjustment, which could dilute existing shareholders.
• Ongoing debt and cash flow pressure, given negative free cash flow and borrowings above cash.